CAJ | 학술논문

目的：：观察脑心多泰胶囊治疗冠心病心绞痛瘀血型的临床疗效。方法：选择136例确诊为冠心病心绞痛瘀血型的病人随机分为观察组与对照组。观察组101例，口服脑心多泰胶囊；对照组35例，口服诺迪康胶囊。服药时间为4周。观察服药期间心绞痛治疗效果及可能的不良反应。结果：两组病人每周心绞痛发作次数显著减少，心绞痛发作持续时间明显缩短。观察组显效率为39.6%，总有效率达91.1%；对照组显效率与总有效率分别为40.0%与85.7%。所有病人服药期间均未出现不良反应。结论：脑心多泰胶囊治疗冠心病心绞痛瘀血型效果确切、服用安全。
목적：：관찰뇌심다태효낭치료관심병심교통어혈형적림상료효。방법：선택136례학진위관심병심교통어혈형적병인수궤분위관찰조여대조조。관찰조101례，구복뇌심다태효낭；대조조35례，구복낙적강효낭。복약시간위4주。관찰복약기간심교통치료효과급가능적불량반응。결과：량조병인매주심교통발작차수현저감소，심교통발작지속시간명현축단。관찰조현효솔위39.6%，총유효솔체91.1%；대조조현효솔여총유효솔분별위40.0%여85.7%。소유병인복약기간균미출현불량반응。결론：뇌심다태효낭치료관심병심교통어혈형효과학절、복용안전。
Objective: To evaluate the therapeutic effects of Naoxinduotai capsule on patients of blood stagnation with angina pectoris associated with coronary atherosclerotic disease.Methods:One hundred and thirty-six patients of blood stagnation with angina pectoris were enrol ed voluntarily in this clinical pharmacological study and randomly divided into experimental group(101 patients) and control group(35 patients).In experimental group, patients took Naoxinduotai capsule for four weeks,and in control group, patients took Nuodikang capsule.Results:The total effective rates of relieving angina pectoris were 91.1% and 85.7% in experimental group and control group,respectively.The frequency of episodes of angina pectoris was dramatical y decreased and the duration of angina pectoris was significantly shortened in both groups.Al patients had no discomfort during the period of investigation.Conclusion:Naoxinduotai capsule has good therapeutic effect on angina pectoris and is safe to be used in the treatment of patients of blood stagnation with angina pectoris associated with coronary atherosclerotic disease.